Publications

You can use the filters to show only results that match your interests

Filter publications
408 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Parallel import licenses granted in August 2018

  2. Marketing authorisations granted in August 2018

  3. Suspended and revoked licences and registrations for manufacturers and wholesalers of medicines and ingredients

  4. Advertising investigations: August 2018

  5. Medicines and Healthcare products Regulatory Agency Privacy Notice

    • MHRA
    • Transparency data
  6. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  7. Human and veterinary medicines: register of licensed manufacturing sites

  8. Human and veterinary medicines: register of licensed wholesale distribution sites

  9. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  10. Register of brokers authorised to deal in human medicines

  11. Medicines: new manufacturing and wholesale dealer licences

  12. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  13. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2018 to 2019

    • MHRA
    • Transparency data
  14. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2017 to 2018

    • MHRA
    • Transparency data
  15. Medicines and Healthcare products Regulatory Agency GPC spending over £500: 2018 - 2019

    • MHRA
    • Transparency data
  16. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  17. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  18. Parallel import licenses granted in July 2018

  19. Marketing authorisations granted in July 2018

  20. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  21. Assistive technology: definition and safe use

  22. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  23. Implementation period: what it means for the life sciences sector

    • DHSC, VMD and MHRA
    • Guidance
  24. Medical devices: UK notified bodies

  25. MHRA fees

    • MHRA
    • Statutory guidance
  26. Medicines and Healthcare products Regulatory Agency board member expenses from January to March 2018

    • MHRA
    • Transparency data
  27. Medicines and Healthcare Products Regulatory Agency Annual Report and Accounts 2017 to 2018

    • MHRA
    • Corporate report
  28. Implementing ‘safety features’ under the Falsified Medicines Directive

    • MHRA
    • Open consultation
  29. Annual review of good clinical practice referrals

    • MHRA
    • Official Statistics
  30. Marketing authorisations granted in June 2018

  31. Parallel import licenses granted in June 2018

  32. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  33. MHRA: business impact target

    • MHRA
    • Research and analysis
  34. Advertising investigations: May 2018

  35. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  36. Medical devices: software applications (apps)

  37. E-learning modules: medicines

    • MHRA
    • Guidance
  38. Medicines: notes for applicants and holders of a wholesale dealer licence or broker registration

  39. Marketing authorisations granted in May 2018

  40. Parallel import licenses granted in May 2018